FR EN MAIN NAVIGATION COMPANY SCIENCE PRODUCTS PARTNERING INVESTORS MEDIA CAREERS CONFERENCE CALL AND WEBCAST FOR Q3 2021 BUSINESS UPDATE - NOV. 16, 2021 Information and replay Previous Next ABOUT INNATE PHARMA Innate Pharma S.A. is a global, clinical-stage oncology-focused biotech company dedicated to improving treatment and clinical outcomes for patients through therapeutic antibodies that harness the immune system to fight cancer. See company profile LATEST NEWS Innate Pharma to participate in the Evercore ISI 4th Annual Healthconx Virtual Conference November 24, 2021 Innate Pharma Third Quarter 2021 Report November 16, 2021 Innate Pharma highlights new NK cell engager data with partner Sanofi at SITC annual meeting November 12, 2021 See all press releases Footer Contact Location Legal Info Terms of use Privacy Notice Cookies notice General Conditions of Purchase Search Search Follow us Stay in touch Subscribe to our newsletter Contact us Location 117, Avenue de Luminy - BP 30191 13 009 Marseille FRANCE +33 (0)4 30 30 30 30 Innate Pharma, Inc. 2273 Research Boulevard, Suite 350 Rockville, MD 20850, USA

Skip to main navigation FR EN MAIN NAVIGATION COMPANY SCIENCE PRODUCTS PARTNERING INVESTORS MEDIA CAREERS SHARE INFORMATION Home Investors Share Information Euronext Paris Segment B Mnemonic code IPH ISIN Code FR0010331421 LEI 9695002Y8420ZB8HJE29 First day of cotation Euronext November 1, 2006 Indices CAC All Shares, CAC All-tradable, CAC Healthcare, CAC Mid&Small, CAC Pharma. & Bio., CAC PME, CAC Small, ENT PEA-PME 150, ENT Tech 40, Next 150, Next Biotech Nasdaq Stock Market Global Select Market Ticker IPHA First day of cotation Nasdaq October 17, 2019 Indices Nasdaq Composite (COMP), Healthcare sector index (IXHC) Total number of shares outstanding 79,329,502 ordinary shares 6,514 preferred shares 2016 7,581 preferred shares 2017 Total number of theoretical voting rights 80,087,342 Total number of exercisable voting rights 80,068,767 Financial year ending date December 31 Investor Relations Overview News & Events Financial and Regulatory Information General Shareholders' Meeting Share Information Stock Quote & Chart Analyst Coverage Investor Kit Corporate Governance Footer Contact Location Legal Info Terms of Use Privacy Notice Cookie Notice Search Search Follow us Stay in touch Subscribe to our newsletter Contact us Location 117, Avenue de Luminy - BP 30191 13 009 Marseille FRANCE +33 (0)4 30 30 30 30 Innate Pharma, Inc. 2273 Research Boulevard, Suite 350 Rockville, MD 20850, USA